On ECHEMI
Home > Drugs > China Resources Zizhu Pharmaceutical Co., Ltd.
China Resources Zizhu Pharmaceutical Co., Ltd.
  • Founded in:

    1980-11-26
  • Country:

    China China
  • Address:

    Building 18, No. 27 Chaoyang North Road, Chaoyang District, Beijing
  • Tax NO.:

    91110000101939631P
  • Registered Funds:

    660.6396 million yuan
  • Website:

  • Email:

Related Drugs
Proglumide Tablets
Proglumide. Its chemical name is (plusmn;)-5-dipropylamino-4-benzoylamino-5-oxo-pentanoic acid.
Name Description Content CAS NO. Registered Holders
Proglumide

This product is a gastrin receptor antagonist, which can significantly inhibit the secretion of gastric acid and pepsin caused by gastrin, but has no obvious effect on the gastric acid secretion caused by histamine and vagus nerve stimulation. It can increase the content of hexosamine in the gastric mucosa, promote glycoprotein synthesis, protect the gastric mucosa and promote healing, improve the symptoms of peptic ulcer and promote ulcer healing. The use of this product to treat peptic ulcer and gastritis does not cause rebound of gastric acid secretion, and gastric acid secretion can remain at a normal level for up to half a year after the treatment is terminated. In addition, this product has a choleretic effect, which prevents stone formation by stimulating bile acid-independent bile secretion, changing the stone-forming factors in bile, and antagonizing CCK to inhibit the gallbladder contraction-promoting effect of endogenous CCK.

More

This product is a gastrin receptor antagonist, which can significantly inhibit the secretion of gastric acid and pepsin caused by gastrin, but has no obvious effect on the gastric acid secretion caused by histamine and vagus nerve stimulation. It can increase the content of hexosamine in the gastric mucosa, promote glycoprotein synthesis, protect the gastric mucosa and promote healing, improve the symptoms of peptic ulcer and promote ulcer healing. The use of this product to treat peptic ulcer and gastritis does not cause rebound of gastric acid secretion, and gastric acid secretion can remain at a normal level for up to half a year after the treatment is terminated. In addition, this product has a choleretic effect, which prevents stone formation by stimulating bile acid-independent bile secretion, changing the stone-forming factors in bile, and antagonizing CCK to inhibit the gallbladder contraction-promoting effect of endogenous CCK.

6620-60-6 7
Xanthinol Nicotinate Tablets
Xanthinol Nicotinate
Name Description Content CAS NO. Registered Holders
Xanthinol nicotinate

It reduces peripheral vascular resistance, increases cardiac output, reduces venous pressure, activates fibrinolysis, reduces fibrinogen levels, prevents platelet aggregation, promotes the synthesis of pyrimidine nucleosides (NAD and NADP), increases the concentration of adenine nucleosides (AMP, ADP and ATP), and finally hinders lipolysis, reducing elevated cholesterol and triglyceride levels

More

It reduces peripheral vascular resistance, increases cardiac output, reduces venous pressure, activates fibrinolysis, reduces fibrinogen levels, prevents platelet aggregation, promotes the synthesis of pyrimidine nucleosides (NAD and NADP), increases the concentration of adenine nucleosides (AMP, ADP and ATP), and finally hinders lipolysis, reducing elevated cholesterol and triglyceride levels

437-74-1 9
Ambroxol Hydrochloride Sustained Release Capsules
trans-4-[(2-amino-3,5-dibromobenzyl)amino]cyclohexanol hydrochloride
Name Description Content CAS NO. Registered Holders
Ambroxol hydrochloride

This product is a mucolytic agent that can increase the secretion of serous glands in the respiratory mucosa and reduce the secretion of mucous glands, thereby reducing sputum viscosity, promoting the secretion of pulmonary surfactant, increasing bronchial ciliary movement, and making sputum easier to cough up.

More

This product is a mucolytic agent that can increase the secretion of serous glands in the respiratory mucosa and reduce the secretion of mucous glands, thereby reducing sputum viscosity, promoting the secretion of pulmonary surfactant, increasing bronchial ciliary movement, and making sputum easier to cough up.

23828-92-4 38
Mint Lozenges
Each tablet contains the following active ingredients: 2 mg menthol, 5 mg sodium benzoate, and 0.6 mg chlorobutanol.
Name Description Content CAS NO. Registered Holders
DL-Menthol

It is a local irritant that can selectively act on the cold receptors of the mucosa, produce a cold reflex, cause the mucosal blood vessels to contract, and produce a therapeutic effect. It has a cooling effect on the mucosa; it can cause blood vessels to contract and reduce edema when used on inflamed mucosa.

More

It is a local irritant that can selectively act on the cold receptors of the mucosa, produce a cold reflex, cause the mucosal blood vessels to contract, and produce a therapeutic effect. It has a cooling effect on the mucosa; it can cause blood vessels to contract and reduce edema when used on inflamed mucosa.

2mg 89-78-1 8
Sodium benzoate

The active ingredient of this product, menthol, is a local irritant. When used locally, it can selectively act on the cold receptors of the mucosa, produce a cold reflex, cause the mucosal blood vessels to contract, and produce a therapeutic effect. When used on the mucosa, it has a cooling effect; when used on inflamed mucosa, it can cause blood vessels to contract and reduce edema.

More

The active ingredient of this product, menthol, is a local irritant. When used locally, it can selectively act on the cold receptors of the mucosa, produce a cold reflex, cause the mucosal blood vessels to contract, and produce a therapeutic effect. When used on the mucosa, it has a cooling effect; when used on inflamed mucosa, it can cause blood vessels to contract and reduce edema.

5mg 532-32-1 23
Chlorobutanol

The active ingredient of this product, menthol, is a local irritant. When used locally, it can selectively act on the cold receptors of the mucosa, produce a cold reflex, cause the mucosal blood vessels to contract, and produce a therapeutic effect. When used on the mucosa, it has a cooling effect; when used on inflamed mucosa, it can cause blood vessels to contract and reduce edema.

More

The active ingredient of this product, menthol, is a local irritant. When used locally, it can selectively act on the cold receptors of the mucosa, produce a cold reflex, cause the mucosal blood vessels to contract, and produce a therapeutic effect. When used on the mucosa, it has a cooling effect; when used on inflamed mucosa, it can cause blood vessels to contract and reduce edema.

0.6mg 57-15-8 4
Sucralfate tablets
The main ingredients of this product are: basic aluminum salt of sucrose sulfate.
Name Description Content CAS NO. Registered Holders
Sucrose sulfate, basic aluminum salt

Not yet clear

More

Not yet clear

0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.